Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefit of Analyzing Exosomes in the Cerebrospinal Fluid During the Medical Care of Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.

NCT03974204 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT03974204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03974204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefit of Analyzing Exosomes in the Cerebrospinal Fluid During the Medical Care of Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Withdrawn
Start date
July 31, 2019
Completion date
October 31, 2023
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, leptomeningeal metastasis